VolitionRx Reports FY22 Cash $10.9M
Cash and cash equivalents as of December 31, 2022 totaled approximately $10.9 million.
Natures Sunshine Products Q4 EPS $0.10 Beats $(0.04) Estimate, Sales $102.75M Beat $100.26M Estimate
Natures Sunshine Products (NASDAQ:NATR) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.04) by 350 percent. This is a 85.29 percent decrease over earnings of $0.68 per
Vaxart Q4 EPS $(0.18) Beats $(0.23) Estimate, Sales $22.00K Miss $670.00K Estimate
Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.23) by 21.74 percent. This is a 20 percent decrease over losses of $(0.15) per share from the same
Jefferies Initiates Coverage On Vitesse Energy with Buy Rating, Announces Price Target of $23
Jefferies analyst Lloyd Byrne initiates coverage on Vitesse Energy (NYSE:VTS) with a Buy rating and announces Price Target of $23.
TD Cowen Downgrades Oak Street Health to Market Perform, Raises Price Target to $39
TD Cowen analyst Gary Taylor downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform and raises the price target from $34 to $39.